Skip to main content

Laraway Financial Advisors Inc

Position in NVO — Novo Nordisk A S

CIK 1908275 SAINT CLOUD, MN

Position in NVO

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$379,013
+$99,493 QoQ
Shares Held
7,906
+3.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#807
of 1,348 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Laraway Financial Advisors Inc holds $5,704,791 across 7 Drug Manufacturers - General names. NVO ranks #4 (6.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NVO
Novo Nordisk A S
This page
7,906 $379,013

All Filings in NVO

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $379,013 7,906
2026-03-31 $279,520 7,606
2025-12-31 $407,345 8,006
2025-09-30 $444,252 8,006
2025-06-30 $511,162 7,406
2025-03-31 $514,272 7,406
2024-12-31 $637,064 7,406
2024-09-30 $881,832 7,406
2024-06-30 $1,057,132 7,406
2024-03-31 $950,930 7,406
2023-12-31 $760,978 7,356
2023-09-30 $696,236 7,656
2023-06-30 $651,851 4,028
2023-03-31 $688,757 4,328